EX-FILING FEES 9 tm2229839d2_ex-filingfees.htm EX-FILING FEES

Exhibit 107

 

Calculation of Filing Fee Tables

 

Form S-3

(Form Type)

 

Voyager Therapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered and Carry Forward Securities

 

   Security
Type
 

Security
Class

Title

  Fee
Calculation
or Carry
Forward
Rule
  Amount
Registered
  Proposed
Maximum
Offering
Price Per
Unit
  Maximum
Aggregate
Offering Price
   Fee Rate   Amount of
Registration
Fee
  

Carry
Forward

Form
Type

   Carry
Forward
File
Number
   Carry
Forward
Initial
Effective
Date
   Filing Fee
Previously
Paid
In
Connection
with
Unsold
Securities
to be
Carried
Forward
 
                                            
Newly Registered Securities 
Fees to Be Paid  Equity  Common Stock, par value $0.001 per share
(1)
  (1)  (1)  (1)   (1)  (1)    (1)   -    -    -    - 
Fees to Be Paid  Equity  Preferred Stock, par value $0.001 per share
(1)
  (1)  (1)  (1)   (1)  (1)    (1)   -    -    -    - 
Fees to Be Paid  Debt 

Debt Securities

(1)

  (1)  (1)  (1)   (1)  (1)    (1)   -    -    -    - 
Fees to Be Paid  Other  Depositary Shares
(1)(2)
  (1)  (1)  (1)   (1)  (1)    (1)  -    -    -    - 
Fees to Be Paid  Other 

Subscription Rights

(1)(3)

  (1)  (1)  (1)   (1)  (1)    (1)   -    -    -    - 
Fees to Be Paid  Other  Warrants
(1)(4)
  (1)  (1)  (1)   (1)  (1)    (1)   -    -    -    - 
Fees to Be Paid  Other 

Purchase Contracts

(1)(5)

  (1)  (1)  (1)   (1)  (1)    (1)   -    -    -    - 
Fees to Be Paid  Other  Units
(1)(6)
  (1)  (1)  (1)   (1)  (1)    (1)   -    -    -    - 
Fees to be Paid  Unallocated (Universal) Shelf  Unallocated (Universal) Shelf  457(o)  (1)  (1)  $300,000,000(1) 

$110.20

per $1,000,000

   $33,060.00    -    -    -    - 
Fees Previously Paid  -  -  -  -  -   -   -    -    -    -    -    - 
Carry Forward Securities 

Carry Forward Securities

  -  -  -  -  -   -   -    -    -    -    -    - 
   Total Offering Amounts     $300,000,000(1)      $33,060.00                     
   Total Fees Previously Paid               -                     
   Total Fee Offsets(7)              $17,162.39                     
   Net Fee Due              $15,897.61                     

 

 

 

 

Table 2: Fee Offset Claims and Sources

 

   Registrant or
Filer Name
  Form
or
Filing
Type
  File
Number
  Initial
Filing
Date
  Filing Date  Fee Offset
Claimed
   Security
Type
Associated
with Fee
Offset
Claimed
  Security Title
Associated
with Fee
Offset
Claimed
  Unsold
Securities
Associated
with Fee
Offset
Claimed
  Unsold Aggregate
Offering Amount
Associated with
Fee Offset
Claimed
   Fee Paid
with Fee
Offset
Source
 
                                     
Rule 457(p)
Fee Offset Claims   Voyager Therapeutics, Inc.  S-3  333-234527  November 6, 2019  -  $17,162.39   Unallocated (Universal) Shelf  Unallocated (Universal) Shelf  Unallocated (Universal) Shelf  $300,000,000(7)   - 
Fee Offset Sources   Voyager Therapeutics, Inc.  S-3  333-234527(7)  N/A  November 6, 2019   -   -  -  -   -   $17,162.39 

 

(1) Pursuant to Instruction 2.A(iii)(b) of Item 16(b) of Form S-3, this information is not required to be included. An indeterminate amount of the securities of each identified class is being registered as may from time to time be offered under this registration statement at indeterminate prices, along with an indeterminate number of securities that may be issued upon exercise, settlement, exchange or conversion of securities offered or sold under this registration statement, as shall have an aggregate initial offering price up to $300,000,000. Pursuant to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, this registration statement also covers any additional securities that may be offered or issued in connection with any stock split, stock dividend or pursuant to anti-dilution provisions of any of the securities. Separate consideration may or may not be received for securities that are issuable upon conversion, exercise or exchange of other securities. In addition, the total amount to be registered and the proposed maximum offering price are estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act.
(2) Each depositary share will be issued under a deposit agreement, will represent an interest in a fractional share or multiple shares of preferred stock and will be evidenced by a depositary receipt.
(3) The subscription rights to purchase shares of common stock or preferred stock or other securities will be offered without additional consideration.
(4) The warrants covered by this registration statement may be warrants for common stock, preferred stock, depositary shares or debt securities issued by the registrant. The registrant may offer warrants separately or together with one or more additional warrants, common stock, preferred stock, depositary shares, or debt securities, or any combination of those securities in the form of units.
(5) The purchase contracts will be issued separately or as a part of units consisting of a purchase contract and either shares of common stock, shares of preferred stock, debt securities, debt obligations of third parties securing the holder’s obligations to purchase the securities under the share purchase contracts or the rights to purchase any securities under this registration statement.
(6) Units may be issued under a unit agreement and will represent an interest in one or more securities registered under this registration statement including shares of common stock or preferred stock, debt securities, depositary shares, subscription rights, warrants or purchase contracts, in any combination, which may or may not be separable from one another.
(7) Pursuant to Rule 457(p) under the Securities Act, the registrant hereby offsets the total registration fee due hereunder by $17,162.39, which represents the portion of the registration fee previously paid with respect to $300,000,000 of unsold securities previously registered on the registrant’s Registration Statement on Form S-3 (File No. 333-234527) filed with the Securities and Exchange Commission on November 6, 2019 and declared effective on December 2, 2019, or the Prior Registration Statement, that was paid on November 6, 2019, in connection with the filing of the Prior Registration Statement. All offerings under the Prior Registration Statement have been completed and no securities were sold thereunder.